RankingsPricing
  1. JP-listed companies
  2. ROHTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Diluted EPS

ROHTO PHARMACEUTICAL CO.,LTD.【JP:4527】

Market cap
¥611.2B
P/E ratio
18.3x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndDiluted EPS (JPY)YoY (%)
Mar 31, 2025135.4+0.17%
Mar 31, 2024135.2+17.28%
Mar 31, 2023115.3-37.25%
Mar 31, 2022183.7+25.53%
Mar 31, 2021146.4+8.65%
Mar 31, 2020134.7+57.26%
Mar 31, 201985.7+5.49%
Mar 31, 201881.2-7.27%
Mar 31, 201787.6+9.87%
Mar 31, 201679.7+5.24%
Mar 31, 201575.7-1.42%
Mar 31, 201476.8+12.16%
Mar 31, 201368.5-1.18%
Mar 31, 201269.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)